CLBK insider adds deferral units; holds 83,294 vested options through 2029
Rhea-AI Filing Summary
Columbia Financial director Noel R. Holland reported transactions on 08/08/2025. The filing shows an acquisition through the company's stock-based deferral plan (phantom stock purchased by a rabbi trust) and a separate disposal of 33,519 common shares. The table lists indirect holdings of 46,280 shares in a SEP-IRA and 3,207 shares attributed to a Stock Award IV.
The report also discloses 83,294 stock options outstanding that are exercisable through 07/23/2029 with an exercise price of $15.60. Stock Awards noted in the filing vest on 03/11/2026. The acquisition via the deferral plan is described as phantom stock units that will be settled in shares upon distribution. The form was signed by a power of attorney on 08/12/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider activity: participation in a deferral plan, a sizable disposition, and continued option holdings; no explicit governance red flags.
The filing documents a non-discretionary purchase of phantom stock units under the Columbia Bank Stock Based Deferral Plan and a separate disposal of 33,519 common shares by Director Noel R. Holland. The presence of indirect holdings (SEP-IRA and Stock Award IV) and a large stock option position suggests compensation-driven movements rather than an unusual corporate governance event. All material mechanics (vesting date and settlement mechanism) are disclosed in the explanations.
TL;DR: Material derivative exposure: 83,294 vested options at $15.60 strike through 07/23/2029; awards vesting in 2026.
The report confirms 83,294 options fully vested and exercisable with a $15.60 exercise price expiring 07/23/2029, which represents potential share issuance upon exercise. Stock awards referenced will vest on 03/11/2026 and phantom units in a rabbi trust will be settled in shares on distribution. These are standard compensation instruments disclosed consistently with Section 16 requirements and should be considered when modeling insider-driven share supply, but the filing does not quantify aggregate percent ownership or market impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 11.625 | $14.33 | $166.58 |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan which vest in one year on March 11, 2026. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
